Home › Cancro ovarico › California › Santa Monica
Studi clinici su Cancro ovarico a Santa Monica, CA
15 studi su Cancro ovarico cercano partecipanti presso sedi a Santa Monica e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
In reclutamentoFase 2
- Saint John's Cancer Institute, Santa Monica
A Study of PHST001 in Advanced Solid Tumors
In reclutamentoFase 1
- Precision NextGen Oncology & Research Center, Beverly Hills · a 6 mi di distanza
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
In reclutamentoFase 1
- Research Site, Santa Monica
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
In reclutamentoStudio osservazionale
- UCLA Medical Center, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- Kivu Trial Site, Santa Monica
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
In reclutamentoFase 1
- UCLA Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · a 6 mi di distanza
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
In reclutamentoFase 1/2
- Research Site, Santa Monica
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
In reclutamentoFase 3
- Site 0104, Beverly Hills · a 6 mi di distanza
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
In reclutamento
- Tower Cancer Research Foundation, Beverly Hills · a 6 mi di distanza
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
In reclutamentoFase 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · a 12 mi di distanza
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
In reclutamentoFase 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · a 4 mi di distanza
- Precision NextGen Oncology & Research Center, Beverly Hills · a 6 mi di distanza
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
In reclutamentoFase 1
- UCLA Department of Medicine - Hematology & Oncology, Santa Monica
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
In reclutamentoFase 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
In reclutamentoFase 1
- University of California, Los Angeles, Santa Monica
A Beta-only IL-2 ImmunoTherapY Study
In reclutamentoFase 1/2
- Providence Saint John's Health Center, Santa Monica
Studi su Cancro ovarico in altre città
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Altri studi a Santa Monica
- Cancro del polmone non a piccole cellule45 studi
- Cancro al seno28 studi
- Cancro colorettale23 studi
- Cancro (tutti i tipi)22 studi
- Cancro metastatico19 studi
- Cancro ai polmoni15 studi
- Cancro alla prostata15 studi
- Carcinoma a cellule squamose della testa e del collo13 studi
- Insufficienza cardiaca11 studi
- Cancro dell'endometrio10 studi
- Cancro dello stomaco9 studi
- Cancro pancreatico9 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.